Blackstone’s Maze Therapeutics MAZE Stock Holding History
Bought
Maintained
Sold
Other funds holding MAZE
Blackstone's MAZE Position: Q2 2026 in Review
Blackstone sold out of Maze Therapeutics (MAZE) in Q2 2026, closing a stake of 24,990 shares — an estimated $746K sold.
Blackstone first reported a position in MAZE in Q1 2026 and held it in 1 quarter. The position peaked at $746K in Q1 2026. 161 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.
- Blackstone reported no remaining Maze Therapeutics position as of Q2 2026 after selling out during the quarter.
- Blackstone sold 24,990 Maze Therapeutics shares in Q2 2026, an estimated $746K.
- Blackstone first reported a position in Maze Therapeutics in Q1 2026 and held it in 1 quarter.
- Blackstone's Maze Therapeutics position peaked at $746K in Q1 2026.
- 161 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.